HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

Anavex Life Sciences Corp.

Contributing Author

Recent Articles by Anavex Life Sciences Corp.

Aug-20
Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer's Disease AVXL GlobeNewswire
Aug-12
Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update AVXL GlobeNewswire
Aug-05
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025 AVXL GlobeNewswire
Jul-31
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease AVXL GlobeNewswire
May-14
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences AVXL GlobeNewswire
May-13
Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update AVXL GlobeNewswire
May-06
Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025 AVXL GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite